CCLA Investment Management Has $130.80 Million Position in Synopsys, Inc. $SNPS

CCLA Investment Management trimmed its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 13.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 278,486 shares of the semiconductor company’s stock after selling 43,944 shares during the period. Synopsys comprises approximately 2.1% of CCLA Investment Management’s portfolio, making the stock its 19th biggest holding. CCLA Investment Management owned about 0.15% of Synopsys worth $130,799,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of SNPS. Brighton Jones LLC raised its holdings in shares of Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after acquiring an additional 50 shares in the last quarter. Integrated Wealth Concepts LLC raised its holdings in shares of Synopsys by 11.6% during the first quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after acquiring an additional 79 shares in the last quarter. NewEdge Advisors LLC raised its holdings in shares of Synopsys by 15.1% during the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after acquiring an additional 395 shares in the last quarter. Jump Financial LLC raised its position in Synopsys by 1,431.6% during the second quarter. Jump Financial LLC now owns 7,612 shares of the semiconductor company’s stock valued at $3,903,000 after acquiring an additional 7,115 shares in the last quarter. Finally, WINTON GROUP Ltd raised its position in Synopsys by 9.2% during the second quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company’s stock valued at $389,000 after acquiring an additional 64 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on SNPS shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Wells Fargo & Company cut their target price on Synopsys from $500.00 to $450.00 and set an “equal weight” rating on the stock in a report on Thursday, February 26th. KeyCorp raised their target price on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Morgan Stanley restated an “equal weight” rating and set a $480.00 target price (down from $550.00) on shares of Synopsys in a report on Wednesday, February 25th. Finally, Rosenblatt Securities dropped their price target on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $531.00.

Check Out Our Latest Report on Synopsys

Synopsys Trading Up 3.1%

Shares of SNPS opened at $410.16 on Thursday. Synopsys, Inc. has a 12-month low of $375.97 and a 12-month high of $651.73. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $78.57 billion, a price-to-earnings ratio of 63.69, a P/E/G ratio of 3.23 and a beta of 1.15. The stock’s 50-day moving average price is $424.56 and its 200 day moving average price is $448.47.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. During the same quarter in the previous year, the firm posted $3.03 EPS. The business’s revenue for the quarter was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.56% of the stock is owned by corporate insiders.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.